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INTRODUCTION
The potential of chemicals to affect male fertility has only recently become a major public issue. Although claims of a progressive reduction in the human sperm count have been made since 1980 (23, 35, 36) , it is only in the last 4 yr that the concept has been given credibility. This followed a survey of publications on semen quality of men with no history of infertility, published between 1938 and 1991, which provided data on 14 ,947 men and included a total of 61 papers (13) . The data suggested that sperm counts in normal adult men had declined by as much as 50% over the 53-yr period with a concomitant increase in other conditions such as testicular cancer, cryptorchidism, and hypospadia. Since publication of the survey, there has been heated debate on the validity of this startling data. Some have criticized the statistical methodology used in the original report (12) . A group of clinicians set out to disprove the data using retrospective analysis of fertile sperm donors at a Paris sperm bank over the last 20 yr. Instead, they confirmed the trend, showing a 2.1 % per annum decline in sperm concentration, a 0.6% per annum decline in the motility of the sperm, and a 0.5% per annum increase in the numbers of morphologically abnormal sperm over the 20-yr period (all p < 0.001) (3). Sharpe has proposed a working hypothesis for the decline, based on the effects of environmental estrogens on the developing testis (53) , and he and his colleagues have tested and supported the hypothesis using a variety of estrogenic xenobiotics on the developing rat (54) . Others are dismissive of the risks of environmental exposure to these compounds altogether (50) .
Despite the controversy over environmental estrogens, there are certainly a large number of structurally diverse chemicals in present use that are known to cause testicular damage in adult laboratory animals. These include various classes of therapeutic drugs, food additives, industrial chemicals, solvents, and agrochemicals [for reviews, see Dixon (22) and Waller et al (60) ]. Despite their known effects in animals, relatively few of these chemicals have been proven to have similar effects in man (51) . There are probably 2 main reasons for this. One is the fact that there are no reliable endpoints for clinically measuring fertility in men. Sperm count is the most commonly used parameter, but it is not an accurate or reproducible measurement and shows significant variation among fertile individuals and among sampling periods in the same individual. The second problem is associated with the difficulties of conducting large-scale, controlled epidemiological studies to determine the effects of chemicals on human fertility. There is a general reluctance of individuals to participate in such studies; sperm samples are not as willingly donated as blood samples, and subjects may be reticent to discuss their sexual performance. However, one of the best publicized male reproductive toxicants in man, the nematocide and soil fumigant dibromochloropropane (DBCP), has long been known to produce testicular atrophy in rats (58) at doses broadly equivalent to those subsequently found to be toxic to humans (61) . In addition to rats and man, it is also an ef-fective testicular toxicant in guinea pigs, hamsters, mice, and rabbits.
In this climate of concern and uncertainty, recent revisions of regulatory guidelines for reproductive, fertility, and developmental toxicity studies have emphasized the importance of histopathology as a sensitive and early indicator of spermatogenic disturbances. Previous guidelines relied heavily on fertility (success in achieving pregnancy) as the main index of male reproductive function. However, a recent collaborative study among Japanese pharmaceutical companies, which investigated the effects of 14 known testicular toxicants over varying time periods, concluded that testicular histology was the most sensitive and reliable method for detecting effects on sperm production, whereas fertility index was the least sensitive (57, 59) . Other studies have reached similar conclusions (41) .
In an effort to improve the sensitivity for detection of testicular toxicants, the regulatory authorities have made a number of recommendations concerning fixation and plane of section of the testes. They have also stressed the importance of good histopathological examination procedures, occasionally making reference to the use of testicular staging in some of the early draft guidelines. However, a great deal of confusion has arisen regarding this term and how it should be addressed by the pathologist. The confusion exists with regulators, with reproductive toxicologists, and even with pathologists, because few people seem to have a clear understanding of what the spermatogenic cycle is or how it should be examined. There is a danger that the confusion will lead to demands to carry out procedures that have little scientific validity and that are very expensive in time and labor. This paper will summarize the current recommendations/requirements of the new guidelines as they relate to histopathological assessment of the male reproductive tract and suggest a rational approach to evaluating testicular toxicity in safety evaluation studies. The role of the spermatogenic cycle in this assessment is crucial, and I will try to put into perspective the correct use (and the potential abuse) of testicular staging.
REQUIREMENTS AND RECOMMENDATIONS OF

REGULATORY GUIDELINES
Revisions of Regulatory Guidelines
Most of the regulatory guidelines for studies on reproduction, fertility, and developmental toxicity are in the process of revision or have recently been reissued. For drug registration, the International Conference on Harmonisation (ICH) Tripartite Guidelines on Detection of Toxicity to Reproduction for Medicinal Products were finalized and endorsed at Step 4 of the ICH process in June 1993 (33) . An amendment to these guidelines, providing additional information on the premating dosing period and on observations to be made during the study, was finalized in December 1995 (34) . These guidelines have been accepted by the regulatory bodies of the United States, the European Community, and Japan. The intention is for these new &dquo;harmonized&dquo; guidelines to re- Abbreviations: HRS = homogenization-resistant spermatid measurement in the testes; PAS = periodic acid-Schiff. place the old Segment 1-3 single-generation studies, introduced by the U.S. Food and Drug Administration (FDA) in 1966 and the Japanese and European equivalents, which all varied slightly in their requirements. The multigeneration study design introduced by the FDA in 1968 for the testing of food additives through 3 generations still remains. The major differences (as they relate to males), between the new draft guidelines and the old guidelines, and between the drug (ICH) and the chemicals/pesticide [Environmental Protection Agency (EPA)/Organisation for Economic Co-operation and Development (OECD)] guidelines, is in the duration of dosing prior to mating and the routine requirement for histopathology of the male reproductive tract (Table I) . The premating period recommended by the EPA and by the OECD for the 2-generation studies is a minimum of 10 wk, which is similar to the old Segment 1 and Segment 2 study guidelines. This duration is based on the length of time taken for testicular spermatogonia to develop into sperm and reach the cauda epididymis in the rat. In contrast, the ICH guidelines recommend a 4-wk premating dosing period for males (which can be cut to 2 wk if justified), provided that adequate histopathology and organ weight data are available from repeat-dose studies of at least 4-wk duration. Given this proviso, the ICH guidelines do not require histopathological examination of the male reproductive tissues from the fertility study unless there is some indication of a fertility problem from the other parameters measured. The OECD reproductive and developmental screen tests (Guidelines 421 and 422) require a 2-wk premating dosing period but demand that dosing of the males must continue for a minimum of 28 days and that all adult testes and epididymides be examined at the end of the study.
The EPA and OECD (two-generation study) guidelines are designed as a comprehensive investigation of all aspects of male fertility, requiring detailed histopathology, full epididymal sperm evaluation, and measurement of daily sperm output using homogenization-resistant spermatid counts from 1 of the pair of testes. In contrast, the ICH guidelines are designed to detect extratesticular effects on fertility, that is, those not easily detected by histopathology, such as effects on mating behavior or on epididymal sperm maturation. Effects on testicular spermatogenesis are expected to be detected in conventional repeat-dose toxicity studies. This being the case, it is imperative that good histopathological techniques and careful examination are extended to the testes from these repeat-dose studies and not just restricted to reproductive/ fertility studies. The ICH guidelines specify that if any positive results on reproductive organs are seen in other toxicity studies, or if the quality of the examinations in these other studies is at all questionable, then a more comprehensive design of the reproductive study should be considered.
It is worth noting that the putative effects of environmental estrogens on the developing testis, which has caused so much recent concern, would probably only be detected by the 2-generation study design proposed by the EPA and OECD guidelines. As proposed by Sharpe et al, the only effects on the testes of males exposed to environmental estrogens in utero and during neonatal development are a reduction in organ weight and a decrease in the daily sperm output (calculated from the homogenization-resistant spermatid count) in the adult testis. No qualitative morphological changes in the testes have been identified (54) . The design of the ICH guidelines where the F1 generation is killed at weaning might identify a weight change in the testes, but the immaturity of the animals precludes measurement of the daily sperm count in the F1 generation, and there would be no effects to be detected in the parental animals.
Recommendations for Testicular Fixation and Histopathological Examination
Until recently, formalin fixation of the testes was the general routine for laboratories carrying out regulatory studies, despite the known disadvantages of this fixative on the morphological detail of the germinal epithelium. Good fixation is essential for detecting the more subtle changes in the seminiferous epithelium. Although per-' fusion fixation and plastic embedding are accepted as the optimal techniques for high-resolution light microscopic . examination, they are neither practical nor necessary for . routine studies. If paraffin wax embedding is used, then . immersion fixation with Bouin's fixative provides an acceptable preservation of the cytoplasmic and nuclear characteristics of the seminiferous epithelium without the severe cellular shrinkage seen with formalin; however, it has the disadvantage of differential tubular shrinkage between peripheral and centrally located tubules. Formalin fixation is acceptable if followed by embedding in glycol methacrylate, as this prevents the cellular shrinkage seen when formalin fixation is followed by processing into paraffin wax. Glycol methacrylate also provides improved morphological resolution in semithin sections and aids visualization of the spermatid acrosome which is necessary to identify the stages of the spermatogenic cycle. Periodic acid-Schiff stain is necessary to stain the glycoprotein component of the acrosome and will allow accurate identification of all 14 stages of the cycle but, with practice, most (excepting Stages II-IV) can be identified in a conventional hematoxylin and eosin-stained section. Both Chapin (14) and Hess (31) have reviewed the characteristics and complimentary interactions of a variety of fixatives and embedding media on the testes, concluding that formalin fixation is only acceptable when combined with glycol methacrylate embedding.
All of these guidelines have emphasized the importance of good histopathological examination for detecting effects on spermatogenesis and make various recommendations for specific fixation techniques, plane of section, and staining methods (Table I ). The EPA and OECD (416) guidelines provide specific advice on the types of changes to be looked for in the testes, such as retained spermatids, loss of germ cell types or layers, or sloughing of germ cells into the tubular lumen. Staging of spermatogenesis is mentioned only in the recently adopted OECD Guidelines 421 and 422 Screening Tests, which state, &dquo;Detailed histological examination should be performed on the ovaries, testes and epididymides (with special emphasis on stages of spermatogenesis and histopathology of interstitial testicular cell structure). &dquo; Although the ICH guidelines make no mention of staging, a statement published by the FDA in Federal Register in 1994 (25) aimed to provide clarification on a number of points in the ICH guidelines when they were at Step 2 of the development process. One of the points addressed was the importance of detecting testicular lesions in repeat-dose studies (as distinct from the reproductive/fertility study). The wording they used was, &dquo;The agency encourages the use of good pathological and histopathological examination techniques in the repeated dose toxicity studies in addition to the staging of spermatogenesis which is routinely employed. &dquo; It is not at all clear what the agency meant by the phrase &dquo;staging of spermatogenesis which is routinely employed.&dquo;
No other guidelines mention staging, not even the draft of OECD Guideline 416 (Two-Generation Reproduction Toxicity Study), which is otherwise very demanding. Despite this, there seems to be a widespread misconception that the new guidelines demand a specific procedure relating to the measurement of some aspect of stages of the spermatogenic cycle, but this is evidently not the case. The single mention of staging in OECD Guidelines 421 and 422 is asking for the pathologist to examine the testis with an awareness of staging rather than making any specific measurement relating to the spermatogenic cycle. This is a reasonable request, because to carry out a meaningful evaluation of testicular pathology it is essential for the pathologist to understand the spermatogenic cycle and to be able to identify the various stages of the spermatogenic cycle.
SPERMATOGENESIS AND THE SPERMATOGENIC CYCLE
A detailed account of spermatogenesis and the spermatogenic cycle is beyond the scope of this review. Some of the important points are outlined here, but for a comprehensive account of the subject the reader is referred to a number of excellent reviews (21, 28, 49) .
Spermatogenesis
Spermatogenesis is the process whereby primitive, diploid, stem cell spermatogonia give rise to highly differentiated, haploid spermatozoa (sperm) (Fig. 1 ). The process comprises a series of mitotic divisions of the sper-matogonia, the final one of which gives rise to the spermatocyte. The spermatocyte is the cell that undergoes the long process of meiosis beginning with duplication of its DNA during preleptotene, pairing and condensing of the chromosomes during pachytene, and finally culminating in 2 reduction divisions to produce the haploid spermatid. The spermatid begins life as a simple round cell but rapidly undergoes a series of complex morphological changes. The nuclear DNA becomes highly condensed and elongated into a head region, which is covered by a glycoprotein acrosome coat, while the cytoplasm becomes a whiplike tail enclosing a flagellum and tightly packed mitochondria. The sequential morphological steps in the differentiation of the spermatid (19 steps of spermiogenesis) provide the basis for the identification of the stages of the spermatogenic cycle in the rat (40) . The same principle has been applied to classify the stages of the spermatogenic cycle in other species (49) .
Arrangement of the Germ Cells within the Tubular Epithelium
In a cross-section of a seminiferous tubule, the germ cells are arranged in discrete layers. Spermatogonia lie on the basal lamina, and spermatocytes are arranged above them and then 1 or 2 layers of spermatids above them. Four generations of cells develop simultaneously and in precise synchrony with each other. As each generation develops, it moves up through the epithelium, continuously supported by Sertoli cells, until the fully formed sperm are released into the tubular lumen (spermiation) (Fig. 2 ).
Regulation of spermatogenesis relies not only on the classical endocrine control involving the hypothalamicpituitary-testicular axis, but also on the complex autocrine and paracrine interactions involving the Sertoli cells, germ cells, Leydig cells, peritubular cells, interstitial macrophages, and endothelial cells of the interstitial vasculature. This is a rapidly advancing area of research that has important and pivotal implications for mechanistic investigations of male reproductive toxicity [for reviews, see Heindel and Treinen (27), Kerr (37) , and Sharpe (52) ].
The Spermatogenic Cycle
The spermatogenic cycle of the rat can be thought of as a 14-frame time-lapse film of germ cell development. Each frame, represented by a &dquo;stage&dquo; is fractionally different from the frame before, as each generation of germ cells develops with time. The synchrony of the development among the 4 generations of cells is such that the precise developmental stage of 1 generation (e.g., spermatogonia) is always accompanied by the same developmental stages of the other 3 generations (e.g., spermatocyte, round spermatid, and elongating spermatid). This results in specific cell associations, which are referred to as stages (Fig. 2) . At the end of the 14-stage cycle, the developmental sequence repeats itself, with the oldest generation having been shed and a new generation commencing. The spermatogenic cycle is simply a developmental process during time, which has been divided into a series of morphologically identifiable stages, the Four generations of cells develop simultaneously and in precise synchrony with each other. During each cycle, 1 generation is shed as sperm into the tubular lumen (at Stage VIII), and another generation begins the process as committed Type A spermatogonia. The cellular make-up of 4 of the stages (I, VIII, XI, and XIV) is shown. The progressive development of each of the generations of cells as they pass through these 4 stages is depicted in the lower half of the diagram. Note that as the cycle repeats itself the cellular associations seen in Stage I of the consecutive cycles are identical but have moved through 1 generation. Type A (A) and intermediate (In) spermatogonia. 1-19 = steps of spermatid development; D = dividing spermatocytes; EP, MP, LP = early, mid, and late pachytene spermatocytes; L = leptotene spermatocytes ; PL = Preleptotene spermatocytes; Z = zygotene spermatocytes. morphological marker being the spermatid acrosome. The division of this cycle into 14 stages is an arbitrary division based on the changing acrosome structure; it can just as easily be divided into a smaller number of stages, using different morphological markers (48) . However, the repeating cycle is a precisely timed event-for example, quence, it is apparent that, when we consider a section I of tubule in a particular stage, we know that a few hours before it was in the preceding stage and a few hours after it will be in the succeeding stage. The duration of the individual stages within that cycle differ from one another but are precisely the same between cycles, and the frequency with which a stage is seen in a testicular section reflects the duration of that stage in the spermatogenic cycle. For example, the most frequent tubular stage seen in a section is Stage VII, and it lasts for 58 hr; the least frequent stages are Stages IX-XI, which only last 7 hr each (49) .
Tubular Staging
The ability to identify and classify any cross-section of seminiferous tubule from a rat or a mouse into 1 of the 14 (rat) or 12 (mouse) stages of the spermatogenic cycle can be easily acquired with a small amount of practice and experience. An excellent account and practical guide of how this is done and the cellular characteristics of each stage are provided by Russell et al (49) and Hess (28) .
Part of the confusion associated with the concept of &dquo;staging&dquo; and testicular evaluation arises from the loose use of the term. People have used &dquo;staging&dquo; to variously mean identifying tubules with respect to their stage in the spermatogenic cycle, quantifying the numbers of tubules in each of the 14 stages of the spermatogenic cycle, or even quantifying the numbers of cells in tubules at different stages of the spermatogenic cycle. Although these techniques are all possible, their applicability in routine evaluation of the testes is very different, and it is important that they are not confused with one another. Quantification of any parameters associated with stages of the spermatogenic cycle should only be carried out with a clear objective in mind and will be discussed later. In this review, the use of the term staging is restricted to the process of identifying tubules with respect to their stage in the spermatogenic cycle.
THE USE OF TUBULAR STAGING IN THE EVALUATION OF TESTICULAR INJURY
Before considering how a knowledge of tubular staging helps in the histopathological evaluation of the testes, it is important to clarify the objective of any particular study. For most regulatory toxicity studies, including reproductive studies, the study is designed to maximize the detection of toxic effects. If damage is seen, then it may be appropriate to characterize the lesion further, but detection and characterization of testicular damage require very different study designs. Identifying tubular stages will help in both types of study but is far more important when characterizing a lesion in its early phase of development.
Detection of Testicular Damage
To evaluate the potential of a chemical to produce testicular damage, the study is usually designed to maximize the exposure of the testis to the chemical using daily dosing over a prolonged (28-/or 90-day) period with high maximum tolerated doses. The intention of this study design is to maintain high plasma concentrations of the compound over an extended period of time such that any target organ toxicity will be apparent at the end of the dosing period.
Germ Cell Death and Depletion. Prolonged dosing with any testicular toxicant, regardless of its mechanism of action, will almost invariably result in germ cell degeneration or loss. It is this that will act as a marker of injury but will provide little useful information regarding the primary target site of toxicity. The reason that germ cells will be affected, regardless of the mechanism of action, is that they are entirely dependent on the coordinated functioning of all other cell types and processes within the testis, and any disturbance of their environment generally results in their death or exfoliation into the tubular lumen. Although the Sertoli cell and Leydig cell are also very sensitive to chemical damage, these cells generally respond with biochemical disturbances rather than cell death.
In a repeat-dose study of 4-13 wk duration using high dose levels, most testicular toxicants will produce a progressive germ cell loss that will be easily detectable by the end of the study, often culminating in tubules containing only Sertoli cells. With this extent and degree of damage, the identity of tubular stages has little relevance and is often impractical due to the absence of spermatids. If there is only a slight loss of germ cells, however, familiarity with the cell populations in the various different stages will enhance recognition of when cells are missing and which cells are missing.
Spermatid Retention. In contrast to obvious germ cell loss, one particular type of germ cell change that can be easily missed is spermatid retention (delayed spermiation) and this is an excellent example of how a knowledge of staging is used to detect testicular damage. Release of the mature Step 19 spermatids into the tubular lumen normally occurs during Stage VIII of the cycle. Consequently, there should be no maturation-phase spermatids visible in Stages IX-XIV; these tubules should only contain a single population of elongating spermatids. Release of the mature spermatids is a function of the Sertoli cell, mediated by specialized cell-to-cell junctions between the Sertoli cell and the spermatids. Damage to the Sertoli cells can prevent release of the spermatids at Stage VIII, resulting in retention and phagocytosis during the subsequent stages or a delay in the spermatid release. The lesion is recognized by the presence of Step 19 spermatids in Stages IX-XIV (Fig. 3 ). Although this may appear a relatively minor change, some studies have shown that this can be the only morphological abnormality associated with infertility (39, 56) . In the case of boric acid (39) , the dose level producing spermatid retention (3,000/4,500 ppm) and the dose level producing germ cell depletion (6,000/9,000 ppm) were shown to be different and could be related to the testicular concentrations of boron. Other Sertoli cell toxicants such as cyclohexylamine (17) and 1,3-dinitrobenzene (30) have also been shown to cause this effect, accompanied by other germ cell effects.
Characterization of Testicular Damage
To identify the target cell of a toxicant, it is necessary to conduct a time course study and identify the earliest pathological changes. In some cases, this can be very early; for example, some phthalate esters produce readily detectable changes in the Sertoli cell within 3 hr of an oral dose (18) , and in other cases, such as with cyclohexylamine, more than 3 wk of daily dosing is required before significant effects are seen (17) . Distinction between primary and secondary cellular damage is critical in this type of study but is not always easy. The early stages of testicular damage induced by dinitrobenzene, a Sertoli cell toxicant (9) , are very similar to those described for 2-methoxyethanol, a spermatocyte toxicant (16) . This is due to the fact that, in the case of dinitrobenzene, the initial Sertoli cell vacuolation is rapidly followed by a cell-specific germ cell degeneration, affecting the pachytene spermatocytes. This is thought to be secondary to the Sertoli cell damage (9) . Conversely, death or depletion of germ cells from the seminiferous epithelium will have biochemical and morphological effects on the Sertoli cell. Potential Target Cells for Toxicity. There are 4 main cellular target sites for toxicity in the testes: the Sertoli cell, the Leydig cell, the germ cells (each has its own specific chemical sensitivity), and the vascular endothelium. A brief summary of the most common responses to injury for these cells is given here; for a more detailed account, see Creasy and Foster (20) . Sertoli Cell Damage: Sertoli cell damage is frequently recognized by inter-/or intracellular vacuoles or by swelling of the basal Sertoli cell cytoplasm. Disturbances in Sertoli cell function will disrupt the structural or metabolic support of the germ cells, resulting in germ cell degeneration or exfoliation into the tubular lumen. Spermatid retention also suggests a disturbance of Sertoli cell junctions.
Leydig Cell Damage: Early morphological changes in Leydig cells are often difficult to recognize by light microscopy. Alteration of testosterone output from the Leydig cell may not be accompanied by detectable changes other than a gradual Leydig cell atrophy, but as testosterone levels fall there should be a stage-specific degeneration of spermatids and/or spermatocytes in Stage VII tubules. This is due to the fact that Stage VII is particularly dependent on testosterone.
Vascular Changes: Changes in the blood flow to the testis by vasoactive compounds or by chemicals damaging the vascular endothelium are likely to reduce oxygen and nutrient movement into the interstitial fluid. Because the germ cells are farthest away from the interstitial vas-culature and are metabolically active, they will be the first to suffer. Even under normal physiological conditions, the germ cells are bordering on anoxia; therefore, small changes in blood flow can have significant effects. The morphological response depends on the severity of the insult; a mild anoxia will result in nonspecific germ cell degeneration and death, but severe disturbances in blood flow, such as those produced by cadmium salts, results in necrosis of all testicular elements including the Sertoli cells and Leydig cells. Germ Cell Effects: Each population of germ cells has its own sensitivity to different chemical toxicants. In some cases, degeneration and necrosis of germ cells can be recognized by the normal criteria of nuclear pyknosis and cytoplasmic eosinophilia. Round spermatids frequently exhibit vesicular or &dquo;ring&dquo; nuclei and fuse to form syncitial cells. However, detection of cell-specific effects on germ cells can be confused by their rapid disappearance due to phagocytosis by the Sertoli cells or by exfoliation into the tubular lumen. This can occur within 24 hr of dosing, such that there may be no evidence of necrotic cells; rather, the cells will be missing (Fig. 5 ). Often, these lesions are not immediately obvious, and in order to recognize that a cell type is missing it is essential to have a clear understanding of which cell types should be in which tubular stages.
Stage-Specific Chemical Effects. In the early stages of damage, many chemicals have been shown to have cellspecific effects that are restricted to specific stages of the spermatogenic cycle, but this specificity is very dependent on dose and duration of dosing (Table II) . Studies using different dose levels of 2-methoxyethanol (up to 500 mg/kg/day) for different durations of dosing demonstrate a range of sensitivity for pachytene spermatocytes : dividing spermatocytes > early pachytene spermatocytes > late pachytene spermatocytes > midpachytene spermatocytes (16, 19) (Table II and Fig. 5 ). However, if the dose level is raised further (750 mg/kg/day), spermatids and spermatogonia are also affected (2) .
The cell-and stage-specific effects of dinitrobenzene, a Sertoli cell toxicant, have also been shown to vary with dose and time. At low doses, the germ cell effects are restricted to pachytene spermatocytes (9) but at higher doses they extend to round spermatids (30) . Duration of dosing also changes the stage specificity. Within 4. -Typical pattern of cell loss in seminiferous tubules (e.g., Stages I-VII) following daily dosing for 4 wk with a chemical that kills pachytene spermatocytes. Top left) On the first day of dosing the pachytene spermatocytes are necrotic. Top right) Phagocytosis of the necrotic cells by the Sertoli cells results in their rapid disappearance and, because dosing continues, newly formed pachytene spermatocytes will also be killed. Examination of the same stage tubule after 2 days or 1 wk of dosing will therefore reveal an absence of pachytene spermatocytes. Bottom left) After 2 wk of dosing (1 spermatogenic cycle duration), pachytene spermatocytes are still missing but round spermatids will also be absent because their precursor cells were destroyed in the previous cycle. Bottom right) Similarly, after 4 wk dosing, pachytene spermatocytes, round spermatids, and elongated spermatids will be absent, leaving only spermatogonia. This progressive loss of subsequent cell types following injury to a precursor cell is termed maturation depletion. ES = elongated spermatids; PS = pachytene spermatocytes; RS = round spermatids; Sg = spermatogonia.
Interpretation of Stage-Specific Effects. The sensitivity of these celland stage-specific effects appears to make them ideal for investigating possible biochemical mechanisms of action for the toxicity. In reality, such investigations are complicated because the different stages of the spermatogenic cycle are associated with a whole variety of cyclical hormonal, metabolic, and biochemical changes within the seminiferous epithelium and between the seminiferous epithelium and the interstitial tissue [for reviews, see Bergh (6) , Parvinen (46) , and Parvinen et al (47) ]. The complexity of these interactions, many of which are still poorly understood, makes investigation of toxicological mechanisms very difficult but the specificity of some of the chemically induced lesions have been used to examine the physiological interactions between one cell type and another. In particular, 2-methoxyethanol and ethane dimethane sulphonate have been widely used to elucidate paracrine regulation (5, 38, 42, 55) .
Cell and stage specificity are only relevant in the initial stages of testicular damage because the continual progression of the spermatogenic cycle means that any celland stage-specific effects are rapidly &dquo;diluted&dquo; by the gradual loss of cells by the process of maturation depletion and movement of the affected stage through the rest of the cycle (Figs. 4 and 5 ). Retrospective analysis of the testis can be undertaken, taking into account the duration of dosing, the duration of the spermatogenic cycle, the cell types affected, and the stages affected at the time of examination. Computer programs are available that will assist the interpretation of such assessments (29) , but ret-rospective analysis relies on various assumptions; in particular, it assumes cell damage occurs on day 1 of dosing. Although this is the case for some well-studied testicular toxicants, it is not always true. Chemicals such as 2,5hexanedione (11, 15) and cyclohexylamine (17) require weeks rather than days of dosing. Any chemical that acts through the hormonal axis, such as ethane dimethane sulphonate (4, 38) , will also have a delayed onset in producing germ cell damage, dependent on the time taken to reduce intratesticular testosterone concentration to a level unable to support spermatogenesis.
In studies designed to characterize a testicular lesion, it is worth considering the inclusion of specialist techniques such as perfusion fixation and/or plastic embedding for high-resolution light microscopy or electron microscopy to study the very early changes or changes in subcellular organelles. Hormone assays can provide important information during the early stages of injury, whereas they have limited applications in a chronic study where hormone changes generally occur as a secondary consequence of spermatogenic disturbances. A knowledge of tubular staging is required for identifying celland stage-specific effects and for analyzing the dynamics of the maturation depletion of subsequent germ cells, following the initial cellular damage. A large amount of information can be gained from this type of study about the precise cellular site of damage and possible biochemical mechanisms of toxicity, which can then be investigated further.
PRACTICAL APPROACH FOR ASSESSING TESTICULAR DAMAGE IN ROUTINE REGULATORY STUDIES
Long-Term Studies (e.g., 90 Days) 1. A significant reduction in testicular weight is likely to be accompanied by obvious germ cell loss. If there is a weight loss, check whether all cell types are depleted or some cell types are spared. For example, if spermatogonia and prepachytene spermatocytes were the only cells present, this would suggest an effect on pachytene spermatocytes. 2. If there is no significant effect on testicular and epididymal weights, there is unlikely to be an obvious effect on testicular morphology, but there could be a subtle effect. Check for inhibited or delayed sperm release by identifying tubules in Stages IX-XI and make sure these stages only have 1 population of elongating spermatids (see Fig. 3 ). 3 . Check tubules in all stages for any evidence of missing or partially depleted germ cell layers or disorganization of the normal regular layering of the different cell populations. This requires a knowledge of which cell types should be in which stages. As a broad generalization, Stages I-VIII should contain spermatogonia, early pachytene spermatocytes, round spermatids, and mature elongated spermatids. Stages IX-XIV should contain spermatogonia, prepachytene spermatocytes, late pachytene spermatocytes, and elongating spermatids. 4 . Look for an increase in degenerate or necrotic germ cells (increased cytoplasmic eosinophilia, nuclear changes, or multinucleate giant cells). Also examine the Leydig cells for signs of atrophy or hypertrophy/ hyperplasia. 5 . Check the epididymis for desquamated germ cells, cell debris, or reduced numbers of sperm. If anything is seen here, go back and check the testis carefully.
Short-Term Studies (e.g., [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] Days)
The responsibility for identifying a testicular lesion in short-term studies rests more heavily on the pathologist. 1. The first step is a qualitative check for basal or prominent tubular vacuolation, visible germ cell degeneration or necrosis, or spermatid retention. Also, examine the Leydig cells for signs of atrophy or hypertrophy/ hyperplasia.
Look for reduced numbers of cells in the different
germ cell layers, but in particular look for a reduction in preleptotene/leptotene spermatocytes (identified as the basal, early spermatocytes in Stages IX-XIV). If these are reduced, spermatogonia have probably been affected, which will ultimately (in 6-8 wk time) result in reduced sperm output and reduced fertility. 3 . Check the epididymis for exfoliated testicular germ cells, cellular debris, and reduced sperm numbers; if anything is seen here, go back and check the testis again carefully.
Recovery Studies
These should be timed as multiples of the spermatogenic process (8 wk in rats, 6 wk in mice). In theory, this allows for any reversible injury to spermatogonia at the end of the dosing period to work its way through maturation depletion and allow full recovery of all cell layers. However, there is often a lag period before all the cells get into full production capacity, so it may take longer than 1 period. If recovery is delayed or the recovery period is less than the 6-8-wk duration, the testes may well show a more severe weight loss and depletion of germ cells in the recovery animals than was present in the terminal kill animals. This is predictable, given the kinetics of cell division and multiplication and the progressive maturation depletion of descendant cohorts of cells during the recovery period.
Additional Studies to
Characterize the Changes
If the preceding examinations show any evidence of testicular damage (in the testis or the epididymis), then subsequent studies may be indicated to determine the initial site of injury and any stage specificity of the initial changes. Choose the lowest dose level that will give a consistent lesion. Try a preliminary time-course study (e.g., 1, 3, 7, 14, and 28 days) with a small number of animals to get an indication of what is happening and then focus on the most interesting time period for an in-depth analysis. Consider embedding in glycol methacrylate for better resolution. In this type of study, a knowledge of staging and the duration of the different stages of the spermatogenic cycle is critical for identifying which cells are being affected and for separation of primary cellular changes/death from secondary cell death and from maturation depletion effects.
QUALITATIVE VERSUS QUANTITATIVE
PARAMETERS OF TESTICULAR DAMAGE
The preceding qualitative approach relies on the pathologist having an adequate knowledge of the spermatogenic cycle and the cellular associations of the different tubular stages in order to recognize subtle disturbances of testicular morphology. In some circumstances, it may be advantageous to quantify testicular changes; if so, there are a number of sensitive parameters that can be used to detect cell loss. The number of replicate measurements made, in terms of tubules per animal and animals per group, depends on the power of the analysis required (probability of detecting a difference of a given magnitude), the size of the difference that is to be detected (e.g., p < 0.05), and the inherent variability among animals of the parameter being measured (coefficient of variation). Berndtson and Thompson (8) carried out studies in the rat to establish the coefficients of variation for a variety of parameters that might be measured as endpoints of testicular toxicity and calculated the number of replicate measurements in terms of tubules and animals required to give statistically valid results. In addition, a series of detailed quantitative studies have been carried out on the effects of DBCP on rat and rabbit testes. In these studies, a variety of parameters were measured and several were found to be sensitive and reliable in detecting the dose-response effects of DBCP (1, 26) . Based on the results of this study, Berndtson et al (7) determined the optimal numbers of tubules and animals that would have been necessary to detect the effects at various levels of sensitivity. The most sensitive parameters were found to be the following:
. Tubular diameter of a selected stage (10-15 tubules/10 rats per group). . Cell counts of spermatocytes or round spermatids, expressed as a ratio of Sertoli cell number in a selected stage (10 tubules/10 rats): leptotene spermatocytes (counted in Stages IX-XI), pachytene spermatocytes (e.g., count in Stage VII), and round spermatids (e.g., count in Stage VII). The applicability of the various parameters to any given chemical obviously depends on the cell specificity of the compound and the duration of dosing, but the preceding selection of cells spans from early germ cells (leptotene spermatocytes) through later germ cells (round spermatids). Although spermatogonia and elongating spermatids might appear more appropriate, these cells are much more difficult to count. Spermatogonia are undergoing multiple mitotic divisions and it is difficult to differentiate the different subpopulations, whereas elongating spermatids weave in and out of the plane of section, making counting difficult. Although cell counting is a sensitive technique, it is costly and time-consuming and should only be considered when a specific question is being asked-for example, determining an accurate no observed effects level or provision of detailed mechanistic information. In comparison, measurement of homogenization-resistant spermatids is a relatively easy and rapid method to quantify maturation-phase spermatids in the testis. It can be automated using a Computer Assisted Sperm Analysis setup or counted in a hemocytometer chamber. This provides a rapid and accurate estimate of daily sperm production and is ideally suited as a routine screening method along with epididymal sperm count (10) .
Quantitating Stage Frequency
Stage frequency is a parameter that could also be measured and has been proposed by some as a means of addressing &dquo;staging&dquo; in regulatory studies. This proposal, however, is based on an inadequate understanding of the role of the spermatogenic cycle in testicular evaluation. Stage frequency is proportional to stage duration, which varies by a factor of 8 between the shortest and longest duration stages (49) . This means that some tubules will be seen very frequently and others will be scarce. Counting the numbers of tubules in different stages will provide a measure of the duration of each of the stages but, to overcome individual variation, Hess et al (32) estimated that in order to detect a difference of 2 SD of the mean, with a 1 °~o error rate, 200 tubules from at least 10 rats per group must be counted. Even if a change is revealed, it is unclear what its toxicological significance would be. There have been various conflicting reports on the ability of some chemicals to alter the dynamics of the spermatogenic cycle, even in the presence of significant cellular damage [reviewed by Hess (32) ]. In addition, there is disagreement on the normal frequencies of the stages in specific strains of rats (32) , such that the use of this parameter as a general marker for detecting testicular toxicity is very questionable.
If a quantitative measure of testicular injury is required, then cell counting is generally the most appropriate parameter to measure. Counting homogenizationresistant spermatids is by far the most efficient in terms of cost-benefit and provides a rapid and relatively sensitive method for detecting changes in sperm output. This method, however, can only detect changes that have worked through to the mature spermatid population. Tubular staging should be used to identify cell loss or, in the case of spermatid retention, inappropriate cell presence ; it should not be used as an endpoint in itself.
